1784.TWO
Price:
$72.9
Market Cap:
$3.71B
BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products. In addition, the company offers Exosome, a novel cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.
Industry
Medical - Diagnostics & Research
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
1784.TWO
According to BIONET Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 48.28. This represents a change of -28.08% compared to the average of 67.13 of the last 4 quarters.
The mean historical PE Ratio of BIONET Corp. over the last ten years is 105.08. The current 48.28 PE Ratio has changed 4.49% with respect to the historical average. Over the past ten years (40 quarters), 1784.TWO's PE Ratio was at its highest in in the December 2023 quarter at 124.90. The PE Ratio was at its lowest in in the March 2023 quarter at 22.37.
Average
105.08
Median
58.51
Minimum
35.00
Maximum
289.67
Discovering the peaks and valleys of BIONET Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.44%
Maximum Annual PE Ratio = 289.67
Minimum Annual Increase = -53.06%
Minimum Annual PE Ratio = 35.00
Year | PE Ratio | Change |
---|---|---|
2024 | 48.10 | 37.44% |
2023 | 35.00 | -31.37% |
2022 | 51.00 | -22.76% |
2021 | 66.02 | -53.06% |
2020 | 140.66 | -51.44% |
The current PE Ratio of BIONET Corp. (1784.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.70
5-year avg
68.16
10-year avg
105.08
BIONET Corp.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BIONET Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BIONET Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BIONET Corp.'s PE Ratio?
How is the PE Ratio calculated for BIONET Corp. (1784.TWO)?
What is the highest PE Ratio for BIONET Corp. (1784.TWO)?
What is the 3-year average PE Ratio for BIONET Corp. (1784.TWO)?
What is the 5-year average PE Ratio for BIONET Corp. (1784.TWO)?
How does the current PE Ratio for BIONET Corp. (1784.TWO) compare to its historical average?